Gyrase and Topoisomerase IV as Antibacterial Targets for Gepotidacin and Zoliflodacin: Teaching Old Enzymes New Tricks. [PDF]
Osheroff N.
europepmc +1 more source
Antibiotic therapy as a risk factor for chronic residual and phantom limb pain after combat-related amputation: a 212-patient cohort study. [PDF]
Ksenchyna K +3 more
europepmc +1 more source
A new therapeutic strategy for spotted fever group rickettsioses: a proposal for evaluating combination therapy with tetracycline and fluoroquinolones. [PDF]
Itoh K +4 more
europepmc +1 more source
Epidemiological burden of multidrug-resistant bacteria and carbapenemases in Northern Morocco: a one-year observational study. [PDF]
El Harrak K +9 more
europepmc +1 more source
Antimicrobial susceptibility and adaptative changes in MRSA lineages exposed to increasing concentrations of fluoroquinolones and chlorhexidine. [PDF]
de Oliveira TLR +6 more
europepmc +1 more source
Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system. [PDF]
Alshammari TM.
europepmc +1 more source
Comparison of the Effect of Co-Trimoxazole versus Co-Trimoxazole and Fluoroquinolones in Urinary Tract Infection Prophylaxis in Kidney Transplant Recipients: A Systematic Review and Meta-analysis. [PDF]
Hakamifard A, Momenzadeh M.
europepmc +1 more source
Clinical experience with fluoroquinolones for treatment of severe Chlamydia psittaci pneumonia with invasive mechanical ventilation in ICU: a retrospective study. [PDF]
Feng B +5 more
europepmc +1 more source
Treatment Approaches for Refractory <i>Mycoplasma genitalium</i> Infection. [PDF]
Tenney R +3 more
europepmc +1 more source

